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Introduction
Vogt-Koyanagi-Harada (VKH) disease is a nontraumatic, 
bilateral, granulomatous panuveitis accompanied by a set 
of systemic symptoms including meningismus, tinnitus, alo-
pecia, poliosis, and vitiligo.1,2 The most commonly observed 
ocular involvements are iridocyclitis, multifocal areas of 
serous retinal detachment, and redness and swelling of the 
optic disc. VKH disease is considered to be an autoimmune 
disease, and specifi c targets in the posterior segment are 
stromal choroidal melanocytes. There is increasing evi-
dence that the disease mechanism is an autoimmune 
T-helper type 1 reaction directed against proteins related 
to stromal choroidal melanocytes.3–5 Therefore, the initial 
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Abstract
Purpose: Indocyanine green angiography (IA) is a highly sensitive method to evaluate choroidal infl am-
matory lesions. We present standardized IA fi ndings of initial acute Vogt-Koyanagi-Harada (VKH) 
disease in Japanese patients before therapeutical intervention.
Methods: Medical records of patients with VKH disease at Tokyo Medical and Dental University 
Hospital and Miyata Eye Hospital were retrospectively analyzed. We analyzed six IA signs: choroidal 
perfusion inhomogeneity, early hyperfl uorescent stromal vessels, hypofl uorescent dark dots (HDDs), 
fuzzy or lost pattern of large stromal vessels, disc hyperfl uorescence, and diffuse late choroidal 
hyperfl uorescence.
Results: Ten patients from the two hospitals were studied. The most constant fi ndings present in all eyes 
were early hyperfl uorescent stromal vessels, HDDs, and either fuzzy or lost pattern of large stromal 
vessels. Disc hyperfl uorescence was present in 18 eyes. Choroidal perfusion inhomogeneity was seen in 
six patients, and diffuse late choroidal hyperfl uorescence was seen to a certain degree in all eyes.
Conclusions: Four of the analyzed signs, including early hyperfl uorescent stromal vessels, HDDs, fuzzy 
or lost pattern of large stromal vessels, and disc hyperfl uorescence were consistent fi ndings in Japanese 
VKH patients. Because the primary lesion is situated in the choroid, IA is the method of choice to 
monitor disease activity in VKH disease. Jpn J Ophthalmol 2010;54:377–382 © Japanese Ophthalmo-
logical Society 2010
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posterior ocular infl ammatory events in VKH disease selec-
tively involve the choroid.
Indocyanine green angiography (IA) is an established 
and highly sensitive method for the evaluation of choroidal 
infl ammatory lesions.6 For posterior uveitis with choroidal 
involvement such as VKH disease, IA has been shown to 
be the most sensitive method to assess and follow choroidal 
infl ammation.7 The fl uorescence of the indocyanine green 
(ICG) dye occurs in the near-infrared wavelengths and can 
be detected through the retinal pigment epithelium, allow-
ing imaging access to the choroidal vascular structures and 
the stroma.8 Since IA has made detection of choroidal 
lesions possible, several reports have been published on the 
choroidal involvement in VKH disease.9–14 Several IA signs 
have been presented in different series, but their practical 
value for clinical use has not been clearly determined as the 
patients analyzed were at different stages of disease and 
therapy. Diverse IA protocols and methods have been used 
to analyze VKH patients at more or less advanced stages of 
disease to describe fi ndings in VKH patients; thus, system-
atization of IA signs has not been possible. Systematization 
of IA signs in VKH disease has been undertaken recently, 
in which a set of IA signs consistently found in VKH patients 
was put forward, which proved very useful for the follow-up 
of the choroidal infl ammation.13,14 Submaximal doses of 
infl ammation suppressive therapy can suppress a clinically 
apparent disease but not the localized choroidal infl amma-
tion that only IA can detect.15 This explains the propensity 
for sunset glow fundus in seemingly controlled disease.
In the current study, we retrospectively analyzed IA 
fi ndings using a standardized IA protocol6 in a homoge-
neous group of Japanese patients presenting an initial acute 
episode of VKH disease at presentation before therapeuti-
cal intervention to determine whether previously proposed 
IA signs13,14 are suffi ciently constant, easily recordable, and 
quantifi able to be useful for the evaluation and monitoring 
of choroidal infl ammation in Japanese patients.
Materials and Methods
Medical records of VKH patients that had a standard IA 
performed before treatment either at Tokyo Medical and 
Dental University Hospital Ophthalmology Department or 
at Miyata Eye Hospital from 2003 to 2006 were retrospec-
tively analyzed. The study followed the tenets of the Dec-
laration of Helsinki. All patients provided informed consent 
after receiving a full explanation of the nature and possible 
consequences of the study.
Inclusion Criteria
The diagnosis was based on clinical symptomatology, cere-
brospinal fl uid examination, and ophthalmoscopic and fl uo-
rescein angiography (FA) fi ndings. Patients who met the 
Revised International Diagnostic Criteria for VKH disease16 
as either complete VKH disease or incomplete VKH disease 
were included in this study. Further inclusion criteria were 
the following: (1) patients with an initial acute infl ammatory 
episode of VKH disease who had an IA performed before 
systemic therapy was introduced, and (2) patients with an 
interval of less than 1 month between onset of symptoms 
and an IA examination.
IA Procedure
A standard IA protocol to analyze choroiditis designed and 
reported earlier6 was used. In Tokyo Medical and Dental 
University Hospital Ophthalmology Department, a Topcon 
TRC-50IA fundus camera coupled to an analogical video 
system was used, and images were later digitalized using a 
commercially available video digitalizing system (WinTV-
PVR2). In Miyata Eye Hospital, a Kowa VX-10i fundus 
camera that was coupled to a digitalizing system (VK-2) was 
used. The angiographic procedure comprises three main 
phases. The early phase of up to 2–3 min shows superim-
posed retinal and choroidal large vessels and physiological 
incipient exudation of the dye through the choriocapillaris 
into the choroidal stroma. The intermediate phase lasts 
about 10 min and shows maximum choroidal stromal back-
ground ICG fl uorescence. The late phase, about 20–28 min 
or more, depending on fundus pigmentation, shows wash-
out of the dye from the general circulation with the large 
choroidal vessels appearing dark against the background 
stromal fl uorescence.
IA Signs
We chose to evaluate IA signs that were estimated to be 
most consistent as well as most useful and easy to evaluate 
and record for the initial evaluation of VKH disease, as 
previously described.13,14 Major IA signs, (1) early choroidal 
perfusion inhomogeneity, which is the same as disturbance/
delay in early choriocapillaris circulation; (2) early hyper-
fl uorescent stromal vessels; (3) hypofl uorescent dark dots 
(HDDs) seen in the intermediate and late phases; (4) fuzzy 
or lost vascular patterns of large stromal vessels seen in the 
intermediate to late angiographic phases; (5) disc hyperfl uo-
rescence; and (6) diffuse late choroidal hyperfl uorescence, 
were analyzed and correlated with clinical fi ndings, fundus 
pictures, FA fi ndings, and optical coherence tomography 
(OCT) fi ndings in some patients. Decimal visual acuity data 
were converted to logarithm of the minimum angle of reso-
lution equivalents for statistical analysis.
Results
Ten patients from the two centers fulfi lled the inclusion 
criteria. Patient data and clinical fi ndings at presentation 
are shown in Table 1. There were fi ve men and fi ve women 
aged between 21 and 79 years (mean 47.2 ± 17.5 years). 
Cerebrospinal fl uid pleocytosis and papillitis were seen in 
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all cases. Mean best-corrected visual acuity (20 eyes) at 
presentation was 0.72 (0.2–1.5). Anterior segment examina-
tion showed anterior uveitis in nine of ten patients (18 of 
20 eyes), and this uveitis was typically granulomatous except 
in one patient. Fundus examination showed bilateral papil-
litis in all patients and multiple serous retinal detachments 
in 18 of 20 eyes. FA showed disc hyperfl uorescence in all 
patients and subretinal fl uid in 18 of 20 eyes. In four of ten 
patients OCT was available at the acute stage and showed 
serous retinal detachments in all patients.
IA fi ndings at presentation are shown in Table 2. Cho-
roidal perfusion inhomogeneity (Fig. 1) was seen in six of 
ten patients presenting some degree of choroidal fi lling 
delay in the early angiographic phase. The results are 
expressed for each patient because one eye of each patient 
had to be chosen for the early frames. Early hyperfl uores-
cent stromal vessels (Fig. 2A, B) were present in all cases. 
HDDs (Fig. 3) were also present in all cases. A fuzzy or lost 
vascular pattern of large stromal vessels in the intermediate 
to late phase (Fig. 4) was also very consistent and present 
in all cases. Disc hyperfl uorescence (Fig. 5A, B) was seen 
in nine of ten cases (18 of 20 eyes). Diffuse late choroidal 
hyperfl uorescence (Fig. 6) was found in all patients. The 
most consistent fi ndings, present in all cases, were early 
hyperfl uorescent stromal vessels, HDDs, fuzzy or lost vas-
cular pattern of large stromal vessels in the intermediate to 
late phase, and diffuse late choroidal hyperfl uorescence.
Discussion
Among the IA signs looked for in VKH disease, early 
hyperfl uorescent stromal vessels, HDDs, fuzzy or lost 
pattern of large stromal vessels in the intermediate to late 
angiographic phase, and disc hyperfl uorescence were most 
consistent and therefore represent useful parameters for 
evaluating choroidal infl ammatory involvement in Japanese 
patients. This set of universally found signs makes IA a 
reliable and precise method to assess and follow VKH 
patients. Analyzing these signs in chronologic order follow-
ing the angiographic time sequence, the detailed fi ndings 
can be summarized as follows with some physiopathological 
explanations.
Choroidal perfusion inhomogeneity (Fig. 1) has been 
described by most reports on IA in VKH disease and put 
forward as an important and specifi c sign.9–11 We found, 
however, that although this was sometimes a very clear sign 
when present, it was less consistent than other IA signs, as 
well as rather nonspecifi c and diffi cult to evaluate and 
quantify.
Early hyperfl uorescent stromal vessels (Fig. 2A, B), 
which indicate severe choroidal stromal infl ammatory vas-
culopathy, are a sign that appears in the early angiographic 
phase (up to 3 min). In later phases, it gives way to diffuse 
late hyperfl uorescence. This sign was easy to evaluate and 
the number of early hyperfl uorescent vessel segments could 
even be counted, making it a quantitative or at least a semi-
quantitative parameter.Ta
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Table 2. IA fi ndings of patients
IA fi ndings
Patient
Present 
(%)1 2 3 4 5 6 7 8 9 10
Choroidal perfusion inhomogeneitya + + − − − − + + + +  60
Early hyperfl uorescent stromal vesselsb +/+ +/+ +/+ +/+ +/+ +/+ +/+ +/+ +/+ +/+ 100
Hypofl uorescent dark dotsb +/+ +/+ +/+ +/+ +/+ +/+ +/+ +/+ +/+ +/+ 100
Fuzzy or lost pattern of large stromal vesselsb +/+ +/+ +/+ +/+ +/+ +/+ +/+ +/+ +/+ +/+ 100
Disc hyperfl uorescenceb +/+ +/+ +/+ +/+ +/+ +/+ +/+ +/+ +/+ −/−  90
Diffuse late choroidal hyperfl uorescenceb +/+ +/+ +/+ +/+ +/+ +/+ +/+ +/+ +/+ +/+ 100
aIn each patient (rather than in each eye) as one eye had to be chosen for the early frames.
bRight eye/left eye.
Figure 1. Choroidal perfusion inhomogeneity (patient 10). White 
arrows show choriocapillary hypoperfusion. This sign is found incon-
sistently and is diffi cult to standardize.
Hypofl uorescent dark dots (HDDs) (Fig. 3), which are 
thought to correspond to choroidal granulomas, were the 
most consistent, most readily recordable angiographic sign, 
allowing also the assessment of choroidal infl ammatory 
activity in a semi-quantitative way. HDDs can be evaluated 
by using an arbitrary semi-quantitative score from 0 to 4 
based on the extension and number of dots, as described 
earlier.17
Fuzzy or lost vascular pattern of large stromal vessels 
(Fig. 4) indicate diffuse infl ammatory vasculopathy of 
stromal vessels. This sign should be looked for in the inter-
mediate to late phase, and it gives way in the late phase to 
diffuse stromal hyperfl uorescence. In case of severe infl am-
mation, the usual pattern of choroidal vessels can even 
become completely lost, preventing identifi cation of indi-
vidual vessels.
The optic disc usually remains dark and nonfl uorescent 
in normal IA. Disc hyperfl uorescence (Fig. 5A, B), rarely 
seen on IA, indicates severe papillitis with a blood–ocular 
barrier rupture suffi ciently important to allow leakage of 
the macromolecular ICG–protein complex from disc capil-
laries. Disc hyperfl uorescence indicates very severe disease 
and usually regresses rapidly after introduction of initial 
induction therapy. It is therefore a good sign for evaluating 
the initial infl ammatory activity of the disease and its 
response to therapy.13
Diffuse late choroidal hyperfl uorescence (Fig. 6), 
although a consistent IA sign found in all our patients, is 
diffi cult to evaluate. The appearance of this sign is too 
dependent on technical factors such as the quantity of gain 
used. It is diffi cult to record and not suffi ciently precise to 
be used in both assessment and follow-up of choroidal 
involvement.
In the present work, our aim was to study whether the 
IA signs previously identifi ed and systematized could be 
applied to Japanese VKH patients and could be considered 
universally acceptable. We chose to evaluate IA signs that 
had been established as the most consistent as well as the 
most useful and easy to evaluate in previously published 
reports.6,13,14 All examined patients showed extensive cho-
roidal involvement even at a very early stage of the disease.
As stated earlier, the diagnosis of VKH disease is essen-
tially clinical, based on bilaterality, multiple serous retinal 
detachments, and papillitis, together with prodromal sys-
temic symptoms such as malaise and headaches as well as 
lymphomonocytic pleocytosis of the cerebrospinal fl uid. FA 
reveals better evidence of these clinical signs, showing disc 
hyperfl uorescence and allowing exact delineation of the 
serous retinal detachments with their leaking points. Simi-
larly, OCT allows clear depiction of the height and extension 
of serous retinal detachments in the macular area, but apart 
from the high-quality images obtained, it provides no essen-
tial additional information that is not already available by 
clinical examination.18 The explanation for this is that clinical 
signs, FA, and OCT, all give merely information on second-
ary infl ammatory events that occur when infl ammation is 
spilling over from the choroid. IA has been found to be par-
ticularly useful for early disease detection when no secondary 
spill-over infl ammation is present as yet.19 The advantage of 
IA is that it allows localized choroidal infl ammation to be 
detected when it has not yet affected adjacent structures and 
become clinically apparent. It has to be kept in mind that in 
VKH disease the primary and main infl ammatory events 
take place and originate within the choroid, where the target 
of the autoimmune infl ammatory reaction is situated.
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BA
Figure 2A, B. Early hyperfl uorescent stromal vessels (patient 10), a consistent indocyanine green angiography (IA) sign found in all our patients. 
A Some of the hyperfl uorescent stromal vessels are outlined by the white arrows. Most stromal vessels are hyperfl uorescent between the horizontal 
arrows in the lower part of the picture. B Early hyperfl uorescent stromal vessels in early phase of angiography (up to 3 min); some are outlined 
by the white arrows. Numerous hypofl uorescent dark dots start to become visible; some are indicated by the black arrows.
Figure 3. Hypofl uorescent dark dots (HDDs) in late angiographic 
phase (patient 4). Numerous HDDs are seen in the late angiographic 
phase. Persistence of HDDs in the late angiographic phase indicates 
that the choroidal infl ammatory foci (granulomas) occupy the whole 
thickness of the choroid and thus do not allow the IA dye to diffuse to 
these areas. Note also that no pattern of stromal vessels can be recog-
nized any more. In this case the stromal vessels are so fuzzy that their 
network cannot be identifi ed any more.
Figure 4. Fuzzy or lost pattern of large stromal vessels (patient 10). 
The stromal vascular pattern is still recognizable but the choroidal 
vessels have a fuzzy appearance (white arrows).
BA
Figure 5A, B. Disc hyperfl uorescence (patient 9). The optic disc usually remains hypofl uorescent unless severe infl ammation is present. A Late-
phase frame showing an extremely hyperfl uorescent disc (white arrows). The black arrows delineate a zone of diffuse late choroidal hyperfl uo-
rescence. B Same case as in A after 1 month of treatment: disc hyperfl uorescence has completely regressed (white arrows), whereas diffuse late 
hyperfl uorescence is still present (black arrows).
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Figure 6. Diffuse late choroidal hyperfl uorescence (patient 10). The 
areas of late diffuse hyperfl uorescence are delineated by the white 
arrows. Within these areas numerous HDDs are visible (black arrows). 
Diffuse late choroidal hyperfl uorescence is diffi cult to standardize and 
is less practical to use as a follow-up sign.
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